Abstract:Cardiovascular diseases (CVDs) persistently rank as a leading cause of premature death and illness worldwide. The Hippo signaling pathway, known for its highly conserved nature and integral role in regulating organ size, tissue homeostasis, and stem cell function, has been identified as a critical factor in the pathogenesis of CVDs. Recent findings underscore the significance of the Yes-associated protein (YAP) and the Transcriptional Coactivator with PDZ-binding motif (TAZ), collectively referred to as YAP/TAZ. These proteins play pivotal roles as downstream components of the Hippo pathway, in the regulation of cardiovascular development and homeostasis. YAP/TAZ can regulate various cellular processes such as cell proliferation, migration, differentiation, and apoptosis through their interactions with transcription factors, particularly those within the transcriptional enhancer associate domain (TEAD) family. The aim of this review is to provide a comprehensive overview of the current understanding of YAP/TAZ signaling in cardiovascular physiology and pathogenesis. We analyze the regulatory mechanisms of YAP/TAZ activation, explore their downstream effectors, and examine their association across numerous cardiovascular disorders, including myocardial hypertrophy, myocardial infarction, pulmonary hypertension, myocardial ischemia-reperfusion injury, atherosclerosis, angiogenesis, restenosis, and cardiac fibrosis. Furthermore, we investigate the potential therapeutic implications of targeting the YAP/TAZ pathway for the treatment of CVDs. Through this comprehensive review, our aim is to elucidate the current understanding of YAP/TAZ signaling in cardiovascular biology and underscore its potential implications for the diagnosis and therapeutic intervention of CVDs.

Regulation of myocardial glucose metabolism by YAP/TAZ signaling

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.

YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

Molecular mechanisms of the mammalian Hippo signaling pathway.

AMPK Modulates Hippo Pathway Activity to Regulate Energy Homeostasis

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

Yap1, the Nuclear Target of Hippo Signaling, Stimulates Heart Growth Through Cardiomyocyte Proliferation but Not Hypertrophy

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Pi3kcb Links Hippo-YAP and PI3K-AKT Signaling Pathways to Promote Cardiomyocyte Proliferation and Survival

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

YAP/TAZ: Molecular pathway and disease therapy

TEAD Mediates YAP-dependent Gene Induction and Growth Control

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells

YAP/TAZ-mediated Regulation Mechanism in Cardiac Development and Pathologic Remodeling

The Regulation and Function of YAP Transcription Co-Activator

An overview of signaling pathways regulating YAP/TAZ activity